Industries

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

31 May 2022  |  North America  |  Market Research

Global RNA Therapeutics Growth Opportunities

Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas

Infographics

×

Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioproce...

The use case for commercial AI in medical imaging focuses on workflow productivity and diagnostic accuracy in a radiology set up. The impending shortage of radiologists, burnout from a constantly growing imaging workload, and higher investments (by both public and private groups) favor the adoption of AI in medical imaging. Several medical imaging ...

16 May 2022  |  North America  |  Market Research

Global Interventional X-ray (IXR) Growth Opportunities

Combining Interventional X-ray and Surgical C-arm with Image-guided Therapies will Accelerate Transformational Growth

Infographics

×

This Frost & Sullivan study analyzes the global interventional X-ray (IXR) market. The research scope includes market trends (utilization of conventional and emerging clinical applications, growth indicators, factors influencing RoI, critical unmet needs and potential game-changing strategies, growth opportunities for fixed IXR and surgical C-arm s...

NGS library preparation incorporates processing steps that convert genomic DNA or RNA into an appropriate format for the selected sequencing technology. The workflow starts with isolating nucleic acids, fragmented, end-repaired, and connected to adapters using methods like ligation or tagmentation. Sequencing applications incorporate whole genome, ...

Frost & Sullivan has recognized remote patient monitoring as one of the top 5 trends in digital health investments. This report addresses how the Internet of Medical Things (IoMT) market offers significant growth opportunities in remote patient monitoring for all healthcare stakeholders and leading information and communication technology (ICT) com...

A digital twin (DT) is a simulated clone of a tangible item or an intangible system/process that users can study independent from its real-world counterpart to aid decision-making. DT technology initially saw application in the production and engineering fields with Industry 4.0, but it has advanced and become revolutionary in the healthcare indust...

The United States is the world’s largest healthcare market, spending over 18% of its GDP on healthcare. Therefore, it is important for healthcare stakeholders to understand how the US healthcare market functions, primarily its insurance system. The US health insurance landscape has seen significant evolution through various legislations, ranging .....

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...